Case Report

Published on 23 Jun 2023

Case Report: An exceptional response to neoadjuvant radiotherapy and chemotherapy in undifferentiated pleomorphic sarcoma following checkpoint inhibitor use

in Cancer Immunity and Immunotherapy

Won Jin Jeon
Jin Hyun Moon
Bryan Pham
Bowon Joung
Laura Denham
Joel Brothers

Frontiers in Oncology

doi 10.3389/fonc.2023.1198292

2,088 views

Original Research

Published on 23 Jun 2023

Integrated analysis of single-cell and Bulk RNA sequencing reveals a malignancy-related signature in lung adenocarcinoma

in Cancer Immunity and Immunotherapy

Mengxi Wu
Zhenyu Wu
Jun Yan
Jie Zeng
Jun Kuang
Chenghua Zhong
Xiaojia Zhu
Yijun Mo
Quanwei Guo
Dongfang Li

Frontiers in Oncology

doi 10.3389/fonc.2023.1198746

2,677 views
1 citation

Review

Published on 22 Jun 2023

You complete me: tumor cell-myeloid cell nuclear fusion as a facilitator of organ-specific metastasis

in Cancer Immunity and Immunotherapy

Alyssa J. Cozzo
Michael F. Coleman
Stephen D. Hursting

Frontiers in Oncology

doi 10.3389/fonc.2023.1191332

3,029 views
2 citations

Original Research

Published on 20 Jun 2023

Comprehensive analysis to identify a novel diagnostic marker of lung adenocarcinoma and its immune infiltration landscape

in Cancer Immunity and Immunotherapy

Ankang Zhu
Dongchen Pei
Yan Zong
Yan Fan
Shuai Wei
Zhisong Xing
Shuailin Song
Xin Wang
Xingcai Gao

Frontiers in Oncology

doi 10.3389/fonc.2023.1199608

2,761 views
5 citations

Editorial

Published on 16 Jun 2023

Editorial: Hallmark of cancer: avoiding immune suppression

in Cancer Immunity and Immunotherapy

Faris Q. B. Alenzi
Benedetta Apollonio
Liusheng Peng
Elias J. Sayour
Michal Sheffer

Frontiers in Oncology

doi 10.3389/fonc.2023.1211456

1,676 views

Review

Published on 16 Jun 2023

Traditional Chinese medicine inhibits PD-1/PD-L1 axis to sensitize cancer immunotherapy: a literature review

in Cancer Immunity and Immunotherapy

Huilan Zheng
Gang Wang
Ming Liu
Hongbin Cheng

Frontiers in Oncology

doi 10.3389/fonc.2023.1168226

5,293 views
10 citations

Review

Published on 16 Jun 2023

CAR-T cells neurotoxicity from consolidated practice in hematological malignancies to fledgling experience in CNS tumors: fill the gap

in Cancer Immunity and Immunotherapy

Lidia Gatto
Ilaria Ricciotti
Alicia Tosoni
Vincenzo Di Nunno
Stefania Bartolini
Lucia Ranieri
Enrico Franceschi

Frontiers in Oncology

doi 10.3389/fonc.2023.1206983

4,048 views
8 citations

Systematic Review

Published on 15 Jun 2023

Checkpoint inhibitors as dual immunotherapy in advanced non-small cell lung cancer: a meta-analysis

in Cancer Immunity and Immunotherapy

Muyesar Alifu
Min Tao
Xiao Chen
Jie Chen
Kejing Tang
Yubo Tang

Frontiers in Oncology

doi 10.3389/fonc.2023.1146905

4,099 views
9 citations

Original Research

Published on 13 Jun 2023

Heterogenous profiles between primary lung cancers and paired brain metastases reveal tumor evolution

in Cancer Immunity and Immunotherapy

Yanming Chen
Xiaoxiao Dai
Ji Wang
Chuming Tao
Ye Wang
Qing Zhu
Zhongyong Wang
Tan Zhang
Qing Lan
Jizong Zhao

Frontiers in Oncology

doi 10.3389/fonc.2023.1026099

1,715 views

Original Research

Published on 13 Jun 2023

PD-1+ IFN-γ+ subset of CD8+ T cell in circulation predicts response to anti–PD-1 therapy in NSCLC

in Cancer Immunity and Immunotherapy

Wenxiu Chen
Yiting Hua
Conghui Shan
Jia Wei
Yutong Zhou
Shiyang Pan

Frontiers in Oncology

doi 10.3389/fonc.2023.1182301

2,100 views

Original Research

Published on 08 Jun 2023

Tumor-associated M2 macrophages in the immune microenvironment influence the progression of renal clear cell carcinoma by regulating M2 macrophage-associated genes

in Cancer Immunity and Immunotherapy

Xiaoxu Zhang
Yang Sun
Yushuo Ma
Chengwen Gao
Youzhi Zhang
Xiaokun Yang
Xia Zhao
Wei Wang
Lisheng Wang

Frontiers in Oncology

doi 10.3389/fonc.2023.1157861

3,261 views
13 citations

Original Research

Published on 05 Jun 2023

Pre-diagnostic prognostic value of leukocytes count and neutrophil-to-lymphocyte ratio in patients who develop colorectal cancer

in Cancer Immunity and Immunotherapy

Giulia Turri
Simone Caligola
Stefano Ugel
Cristian Conti
Silvia Zenuni
Valeria Barresi
Andrea Ruzzenente
Giuseppe Lippi
Aldo Scarpa
Vincenzo Bronte

Frontiers in Oncology

doi 10.3389/fonc.2023.1148197

1,619 views
1 citation

Original Research

Published on 05 Jun 2023

NLRX1 functions as a tumor suppressor in Pan02 pancreatic cancer cells

in Cancer Immunity and Immunotherapy

Margaret A. Nagai-Singer
Holly A. Morrison
Mackenzie K. Woolls
Katerina Leedy
Khan Mohammad Imran
Juselyn D. Tupik
Irving C. Allen

Frontiers in Oncology

doi 10.3389/fonc.2023.1155831

2,345 views
6 citations

Original Research

Published on 31 May 2023

IL-22BP controls the progression of liver metastasis in colorectal cancer

in Cancer Immunity and Immunotherapy

Anastasios D. Giannou
Jan Kempski
Tao Zhang
Jöran Lücke
Ahmad Mustafa Shiri
Dimitra E. Zazara
Ioannis Belios
Andres Machicote
Philipp Seeger
Theodora Agalioti

Frontiers in Oncology

doi 10.3389/fonc.2023.1170502

2,638 views
1 citation

Editorial

Published on 31 May 2023

Editorial: Tumor microenvironment, inflammation, and resistance to immunotherapies

in Cancer Immunity and Immunotherapy

Julie Decock
Giuseppina Comito
Apostolos Zaravinos

Frontiers in Oncology

doi 10.3389/fonc.2023.1215332

1,338 views

Original Research

Published on 31 May 2023

Immunotherapy-related adverse events in real-world patients with advanced non-small cell lung cancer on chemoimmunotherapy: a Spinnaker study sub-analysis

in Cancer Immunity and Immunotherapy

Shobana Anpalakhan
Prerana Huddar
Roya Behrouzi
Alessio Signori
Judith Cave
Charles Comins
Alessio Cortellini
Alfredo Addeo
Carles Escriu
Hayley McKenzie

Frontiers in Oncology

doi 10.3389/fonc.2023.1163768

2,772 views
4 citations

Navigation group

Articles

Case Report: An exceptional response to neoadjuvant radiotherapy and chemotherapy in undifferentiated pleomorphic sarcoma following checkpoint inhibitor use

Integrated analysis of single-cell and Bulk RNA sequencing reveals a malignancy-related signature in lung adenocarcinoma

You complete me: tumor cell-myeloid cell nuclear fusion as a facilitator of organ-specific metastasis

Comprehensive analysis to identify a novel diagnostic marker of lung adenocarcinoma and its immune infiltration landscape

Editorial: Hallmark of cancer: avoiding immune suppression

Traditional Chinese medicine inhibits PD-1/PD-L1 axis to sensitize cancer immunotherapy: a literature review

CAR-T cells neurotoxicity from consolidated practice in hematological malignancies to fledgling experience in CNS tumors: fill the gap

Checkpoint inhibitors as dual immunotherapy in advanced non-small cell lung cancer: a meta-analysis

Heterogenous profiles between primary lung cancers and paired brain metastases reveal tumor evolution

PD-1+ IFN-γ+ subset of CD8+ T cell in circulation predicts response to anti–PD-1 therapy in NSCLC

Tumor-associated M2 macrophages in the immune microenvironment influence the progression of renal clear cell carcinoma by regulating M2 macrophage-associated genes

Pre-diagnostic prognostic value of leukocytes count and neutrophil-to-lymphocyte ratio in patients who develop colorectal cancer

NLRX1 functions as a tumor suppressor in Pan02 pancreatic cancer cells

IL-22BP controls the progression of liver metastasis in colorectal cancer

Editorial: Tumor microenvironment, inflammation, and resistance to immunotherapies

Immunotherapy-related adverse events in real-world patients with advanced non-small cell lung cancer on chemoimmunotherapy: a Spinnaker study sub-analysis